The Global Fund should extend its mandate to include universal access to hydroxyurea
Authors:
- 3 October 2024
- journal article
- editorial
- Published by Elsevier in The Lancet Haematology
- Vol. 11 (11) , e810-e811
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionThe Lancet Haematology, 2023
- Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021The Lancet Haematology, 2023
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan AfricaNew England Journal of Medicine, 2019